Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.

Show other versions (1)

BACKGROUND: The lowering of cholesterol concentrations in individuals at high risk of cardiovascular disease improves outcome. No study, however, has assessed benefits of cholesterol lowering in the primary prevention of coronary heart disease (CHD) in hypertensive patients who are not conventional...

Full description

Bibliographic Details
Main Authors: Sever, P, Dahlöf, B, Poulter, N, Wedel, H, Beevers, G, Caulfield, M, Collins, R, Kjeldsen, SE, Kristinsson, A, McInnes, G, Mehlsen, J, Nieminen, M, O'Brien, E, Ostergren, J
Format: Journal article
Language:English
Published: 2003

Similar Items